BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 20015572)

  • 41. [Clinical observation on treatment of non-small cell lung cancer with Chinese herbal medicine combined with bronchial arterial infusion chemotherapy].
    Liu CL; Wang YD; Jin XJ
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2001 Aug; 21(8):579-81. PubMed ID: 12575569
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Concomitant chemoradiotherapy using pemetrexed and carboplatin for unresectable stage III non-small cell lung cancer (NSCLC): preliminary results of a phase II study.
    Xu Y; Ma S; Ji Y; Sun X; Jiang H; Chen J; Du X; Zheng Y; Qiu G
    Lung Cancer; 2011 Jun; 72(3):327-32. PubMed ID: 21056507
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Efficacy and safety of Xiao-ai-ping injection add-on therapy to chemotherapy in patients with non-small cell lung cancer: A systematic review and meta-analysis.
    Li A; Liu S; Zhang H; Lin M; Guo L; Yuan C; Li Z; Xu J; Wang T
    Medicine (Baltimore); 2023 Oct; 102(40):e35483. PubMed ID: 37800773
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Enhancing effect of compound Kusheng injection in combination with chemotherapy for patients with advanced non-small cell lung cancer].
    Fan CX; Lin CL; Liang L; Zhao YY; Liu J; Cui J; Yang QM; Wang YL; Zhang AR
    Zhonghua Zhong Liu Za Zhi; 2010 Apr; 32(4):294-7. PubMed ID: 20510083
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Randomised phase II trial of 4 dose levels of single agent docetaxel in performance status (PS) 2 patients with advanced non-small cell lung cancer (NSCLC): DOC PS2 trial. Manchester lung cancer group.
    Califano R; Griffiths R; Lorigan P; Ashcroft L; Taylor P; Burt P; Lee L; Chittalia A; Harris M; Faivre-Finn C; Thatcher N; Blackhall F
    Lung Cancer; 2011 Sep; 73(3):338-44. PubMed ID: 21296449
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Efficacy and Safety of Chinese Herbal Medicine on Ovarian Cancer After Reduction Surgery and Adjuvant Chemotherapy: A Systematic Review and Meta-Analysis.
    Wang R; Sun Q; Wang F; Liu Y; Li X; Chen T; Wu X; Tang H; Zhou M; Zhang S; Xiao Y; Huang W; Wang CC; Li L
    Front Oncol; 2019; 9():730. PubMed ID: 31475101
    [No Abstract]   [Full Text] [Related]  

  • 47. Chinese herbal medicines of supplementing Qi and nourishing Yin combined with chemotherapy for non-small cell lung cancer: A meta-analysis and systematic review.
    Shen S; Jiang S
    J Cell Biochem; 2019 Jun; 120(6):8841-8848. PubMed ID: 30730073
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A systematic review of quality of life associated with standard chemotherapy regimens for advanced non-small cell lung cancer.
    Tanvetyanon T; Soares HP; Djulbegovic B; Jacobsen PB; Bepler G
    J Thorac Oncol; 2007 Dec; 2(12):1091-7. PubMed ID: 18090580
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Adjuvant paclitaxel plus carboplatin compared with observation in stage IB non-small-cell lung cancer: CALGB 9633 with the Cancer and Leukemia Group B, Radiation Therapy Oncology Group, and North Central Cancer Treatment Group Study Groups.
    Strauss GM; Herndon JE; Maddaus MA; Johnstone DW; Johnson EA; Harpole DH; Gillenwater HH; Watson DM; Sugarbaker DJ; Schilsky RL; Vokes EE; Green MR
    J Clin Oncol; 2008 Nov; 26(31):5043-51. PubMed ID: 18809614
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Efficacy of the MAGE-A3 cancer immunotherapeutic as adjuvant therapy in patients with resected MAGE-A3-positive non-small-cell lung cancer (MAGRIT): a randomised, double-blind, placebo-controlled, phase 3 trial.
    Vansteenkiste JF; Cho BC; Vanakesa T; De Pas T; Zielinski M; Kim MS; Jassem J; Yoshimura M; Dahabreh J; Nakayama H; Havel L; Kondo H; Mitsudomi T; Zarogoulidis K; Gladkov OA; Udud K; Tada H; Hoffman H; Bugge A; Taylor P; Gonzalez EE; Liao ML; He J; Pujol JL; Louahed J; Debois M; Brichard V; Debruyne C; Therasse P; Altorki N
    Lancet Oncol; 2016 Jun; 17(6):822-835. PubMed ID: 27132212
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Assessment on the Efficacy and Safety of Aidi Injection Combined with Vinorelbine and Cisplatin for Treatment of Advanced Nonsmall Cell Lung Cancer.
    Zhao HY; Zhou HY; Wang YT; Chen W; Qi SY; Cao JL; Li GH
    Chin Med J (Engl); 2016 Mar; 129(6):723-30. PubMed ID: 26960377
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effectiveness and safety of bevacizumab for unresectable non-small-cell lung cancer: a meta-analysis.
    Yang K; Wang YJ; Chen XR; Chen HN
    Clin Drug Investig; 2010; 30(4):229-41. PubMed ID: 20225906
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Meta-analysis on treatment of non-small cell lung cancer with brucea javanica oil emulsion in combination with platinum-contained first-line chemotherapy].
    Wang Q; Wang M; He X; Gao T; Cao H; Dou W; Tian J
    Zhongguo Zhong Yao Za Zhi; 2012 Jul; 37(13):2022-9. PubMed ID: 23019891
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Topical herbal medicine for treatment of diabetic peripheral neuropathy: a systematic review of randomized controlled trials.
    Chen W; Luo YF; Liu JP
    Forsch Komplementmed; 2011; 18(3):134-45. PubMed ID: 21701182
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Shenyi Capsule () plus Chemotherapy versus Chemotherapy for Non-Small Cell Lung Cancer: A Systematic Review of Overlapping Meta-Analyses.
    Guo XW; Hu ND; Sun GZ; Li M; Zhang PT
    Chin J Integr Med; 2018 Mar; 24(3):227-231. PubMed ID: 29043599
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Effectiveness of adjuvant chemotherapy in patient with early stages of non-small cell lung cancer depending on proliferation index of tumor].
    Kolesnik AP
    Lik Sprava; 2014; (1-2):110-7. PubMed ID: 24908971
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Shenlingcao oral liquid for patients with non-small cell lung cancer receiving adjuvant chemotherapy after radical resection: A multicenter randomized controlled trial.
    Liu Y; Luo X; Liu J; Ma Y; Tan J; Wang W; Hu J; Fu X; Xu L; Yu F; Xu S; Ma H; Yu X; You Q; Wang Z; Li L; Zhang X; Sun X
    Phytomedicine; 2023 May; 113():154723. PubMed ID: 36871476
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Role of adjuvant chemotherapy in NSCLC (stages I to III).
    Coleman MH; Bueno R
    Surg Oncol Clin N Am; 2011 Oct; 20(4):757-67. PubMed ID: 21986270
    [TBL] [Abstract][Full Text] [Related]  

  • 59. First-line cisplatin with docetaxel or vinorelbine in patients with advanced non-small-cell lung cancer: a quality of life directed phase II randomized trial of Gruppo Oncologico Italia Meridionale.
    Gebbia V; Lorusso V; Galetta D; Caruso M M; Palomba G; Riccardi F; Borsellino N; Carrozza F; Leo S; Ferraù F; Cinieri S; Mancuso G; Mancarella S; Colucci G
    Lung Cancer; 2010 Aug; 69(2):218-24. PubMed ID: 19910076
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Adjuvant therapy with Astragalus membranaceus for post-stroke fatigue: a systematic review.
    Xu L; Xu XY; Hou XQ; Wang FG; Gao S; Zhang HT
    Metab Brain Dis; 2020 Jan; 35(1):83-93. PubMed ID: 31440984
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.